gvtcx

Magnox Radiopharmaceuticals

NUCLEAR DECOMMISSIONING AUTHORITY Published 17 Feb 2023 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 73000000
Deadline2 Feb 2023
Contract start17 Feb 2023
Contract end2 Apr 2023
Procedureselective
SME suitableYes
OCIDocds-b5fd17-72850284-3cca-45b3-a706-864571170349

Award

SupplierValueDateStatus
TUV SUD LTD £49,953 17 Feb 2023 active

description

Magnox Radiopharmaceuticals - Call off from NDA9/00916 Stategy Framework.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
17 Feb 2023 Award (award) · 6a48c127-745b-4111-b6a5-7011fdf0d6d4-616227

more from NUCLEAR DECOMMISSIONING AUTHORITY

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.